BOC Sciences Announces Its Participation in the Upcoming TIDES USA Conference

Share this news:

Recently, BOC Sciences announced to participate in the TIDES USA (Oligonucleotide & Peptide Therapeutics) conference.

Recently, BOC Sciences announced to participate in the TIDES USA (Oligonucleotide & Peptide Therapeutics) conference to be held in Boston from September 20th to 23rd to have in-depth exchanges with more professionals in the RNA industry.

BOC Sciences has a sub-brand called BOC RNA, which mainly focuses on RNA technology and its broad prospects in disease treatment. BOC RNA provides a comprehensive range of RNA-related products and services, including siRNA design, synthesis, analysis, coupling, delivery, and mRNA vaccines related services, which can basically cover all the development processes of RNA drugs. And it can also provide oligonucleotide analysis and purification, oligonucleotide synthesis and oligonucleotide modification services.

Oligonucleotide analysis and purification
The synthesized oligonucleotides need to be analyzed and purified to obtain high-purity oligonucleotides that can be used for drug discovery or biomedical research. Due to the large molecular weight (5000-15000), high electronegativity and hydrophobicity of oligomers, BOC RNA has developed a hexafluoroisopropanol system to analyze the oligo due to weak retention and poor peak sharp using traditional RP-HPLC. Oligonucleotide purification methods include Desalting, Cartridge purification, RP-HPLC, IE-HPLC, Gel Filtration, etc.

Oligonucleotide synthesis
A wide range of oligonucleotides and their derivatives, including natural DNA, siRNA, mRNA and DNA/RNA oligonucleotides, or non-natural and more stable oligonucleotides can be synthesized, making them useful for basic and biomedical research Life science tools and reagents (including DNA sequencing, PCR, SNP research, gene synthesis, NGS, qPCR, biochips and siRNA expression, etc.). These synthetic oligonucleotides can also be used for in vitro diagnostics (IVD) and molecular diagnostics (MDx) and other therapeutic research.

Oligonucleotide modification
High-quality oligonucleotides can be obtained through artificial modification methods including backbone modification, base modifications, phosphorylated modification, spacer modification. Modified oligonucleotides help to understand the mechanisms of many biochemical reactions and processes. They can be used as probes in various diagnostic and therapeutic applications, and can be used in drug discovery and disease treatment (nucleic acid vaccines and nucleic acid drugs) research.

TIDES USA (Oligonucleotide and Peptide Therapy Conference) is dedicated to accelerating the development and commercialization of oligonucleotides, peptides, mRNA and genome editing products from early discovery to later stages. BOC Sciences (Booth No. #874) stated that it hopes to exchange more insights about the RNA industry with professionals participating in the conference.

For more information about BOC Sciences's participation in TIDES USA, please visit the website:

About BOC Sciences
BOC Sciences has professional experts who focus on research in many fields such as pharmaceuticals, chemistry, and life sciences, providing high-quality products and services for scientists and researchers in the global academic and industrial circles. BOC RNA is a sub-brand of BOC Sciences, which mainly focuses on the latest RNA technology, including siRNA design, synthesis, analysis, coupling and delivery, and mRNA vaccine development.

Contact Info:
Name: Alex Brown
Email: Send Email
Organization: BOC Sciences

Release ID: 89039712

Name: Alex Brown
Email: Send Email
Organization: BOC Sciences